DE69943299D1 - Zubereitung mit langandauernder verlängerter arzneiwirkstofffreisetzung - Google Patents

Zubereitung mit langandauernder verlängerter arzneiwirkstofffreisetzung

Info

Publication number
DE69943299D1
DE69943299D1 DE69943299T DE69943299T DE69943299D1 DE 69943299 D1 DE69943299 D1 DE 69943299D1 DE 69943299 T DE69943299 T DE 69943299T DE 69943299 T DE69943299 T DE 69943299T DE 69943299 D1 DE69943299 D1 DE 69943299D1
Authority
DE
Germany
Prior art keywords
preparation
farming
long
extended drug
relief
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69943299T
Other languages
English (en)
Inventor
Akihiko Sano
Hiroo Maeda
Masako Kajihara
Syunsuke Tani
Toshihiko Sugie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd
Application granted granted Critical
Publication of DE69943299D1 publication Critical patent/DE69943299D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)
DE69943299T 1998-09-10 1999-09-06 Zubereitung mit langandauernder verlängerter arzneiwirkstofffreisetzung Expired - Lifetime DE69943299D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25617098 1998-09-10
PCT/JP1999/004809 WO2000015199A1 (fr) 1998-09-10 1999-09-06 Preparation de liberation prolongee de medicament a effet durable

Publications (1)

Publication Number Publication Date
DE69943299D1 true DE69943299D1 (de) 2011-05-05

Family

ID=17288890

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69943299T Expired - Lifetime DE69943299D1 (de) 1998-09-10 1999-09-06 Zubereitung mit langandauernder verlängerter arzneiwirkstofffreisetzung

Country Status (18)

Country Link
US (1) US6756048B1 (de)
EP (1) EP1112739B1 (de)
JP (1) JP4753471B2 (de)
KR (1) KR100602823B1 (de)
CN (1) CN1198599C (de)
AT (1) ATE502626T1 (de)
AU (1) AU754996B2 (de)
BR (1) BR9913596B1 (de)
CA (1) CA2342587C (de)
DE (1) DE69943299D1 (de)
DK (1) DK1112739T3 (de)
ES (1) ES2360180T3 (de)
MX (1) MXPA01002609A (de)
NZ (1) NZ510400A (de)
PT (1) PT1112739E (de)
TW (1) TWI246928B (de)
WO (1) WO2000015199A1 (de)
ZA (1) ZA200101853B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
US7363091B1 (en) * 2001-07-11 2008-04-22 Pacesetter Inc. Method of molding silicone elastomer drug carrier in an endocardial lead
NZ528240A (en) * 2003-09-23 2006-03-31 Graham Francois Duirs And Lind Treatment and control device
GB2410748A (en) * 2004-02-03 2005-08-10 Johnson & Johnson Medical Ltd Medicated polyurethane foams
EP1879552B1 (de) * 2005-03-14 2016-02-17 Biotegra, Inc. Arzneimittelabgabezusammensetzungen und dazugehörige verfahren
WO2009029958A2 (en) * 2007-08-30 2009-03-05 Sunstorm Research Corporation Implantable delivery device
CN103140226B (zh) 2010-08-06 2015-07-08 大日本住友制药株式会社 用于治疗脊髓损伤的制剂
JP5898619B2 (ja) * 2010-08-06 2016-04-06 大日本住友製薬株式会社 水溶性薬物放出制御製剤
CN102908316B (zh) * 2012-11-12 2014-07-30 西南大学 伊维菌素水溶性固体分散体及其制备方法
AU2016272089B2 (en) 2015-06-03 2021-02-18 Triastek, Inc. Dosage forms and use thereof
CN104983695B (zh) * 2015-07-17 2018-01-09 江西博莱大药厂有限公司 一种盐酸头孢噻呋脂质体冻干剂及其制备方法
JP6878417B2 (ja) * 2016-02-17 2021-05-26 トリアステック インコーポレイテッド 剤形およびそれらの使用
CN110022794A (zh) * 2016-10-05 2019-07-16 泰坦医药品公司 具有减少的突释的用于药物递送的可植入装置
CN116270513A (zh) 2018-01-09 2023-06-23 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型
CN112353765B (zh) * 2020-11-09 2022-05-31 山东华辰制药有限公司 一种头孢噻呋微球的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279996A (en) 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents
DE2445971A1 (de) * 1974-09-24 1976-04-08 Schering Ag Arzneimittelwirkstofftraeger ii
US4191741A (en) 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
DE2902414A1 (de) 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
JPS5793909A (en) * 1980-12-03 1982-06-11 Sankyo Co Ltd Carcinostatic pharmaceutical having directivity to specific internal organ and its preparation
JPS5944310A (ja) * 1982-09-06 1984-03-12 Nippon Kayaku Co Ltd シリコ−ンゴム系徐放性製剤
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
JPH0761959B2 (ja) * 1985-10-11 1995-07-05 住友製薬株式会社 シリコンエラストマ−系徐放性製剤
EP0230654B1 (de) 1985-12-28 1992-03-18 Sumitomo Pharmaceuticals Company, Limited Arzneimittel mit verzögerter stossweiser Freisetzung
JPH04224513A (ja) * 1990-12-26 1992-08-13 Olympus Optical Co Ltd 徐放剤用担体およびその製造方法
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
JPH0778017A (ja) * 1993-06-30 1995-03-20 Kobe Steel Ltd 動作物体間の干渉チェック方法及びその装置
US5490962A (en) * 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
JPH07330581A (ja) * 1994-06-08 1995-12-19 Mitsui Toatsu Chem Inc 埋込型徐放性免疫抑制剤

Also Published As

Publication number Publication date
CA2342587C (en) 2008-11-18
TWI246928B (en) 2006-01-11
MXPA01002609A (es) 2002-04-08
EP1112739B1 (de) 2011-03-23
WO2000015199A1 (fr) 2000-03-23
AU754996B2 (en) 2002-11-28
KR100602823B1 (ko) 2006-07-19
BR9913596A (pt) 2001-05-22
PT1112739E (pt) 2011-03-31
NZ510400A (en) 2003-03-28
JP4753471B2 (ja) 2011-08-24
KR20010072691A (ko) 2001-07-31
BR9913596B1 (pt) 2014-12-23
CN1198599C (zh) 2005-04-27
DK1112739T3 (da) 2011-04-26
ZA200101853B (en) 2001-11-14
US6756048B1 (en) 2004-06-29
EP1112739A4 (de) 2009-05-27
CA2342587A1 (en) 2000-03-23
AU5449399A (en) 2000-04-03
ATE502626T1 (de) 2011-04-15
EP1112739A1 (de) 2001-07-04
CN1316900A (zh) 2001-10-10
ES2360180T3 (es) 2011-06-01

Similar Documents

Publication Publication Date Title
DE69943299D1 (de) Zubereitung mit langandauernder verlängerter arzneiwirkstofffreisetzung
DE3579068D1 (de) Arzneimittelenthaltende matrizen fuer einfuehrungen in zonen mit cellularen lesionen.
DK0850068T3 (da) Lipidekstrakt med antiinflammatorisk aktivitet
WO1998029105A3 (en) Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations
DE69942928D1 (de) Therapeutische formulierung zur verabreichung von tolterodin mit kontrollierter freisetzung
BR9910793B1 (pt) composiÇço farmacÊutica implantÁvel em forma de bastço de liberaÇço controlada que tem estrutura em multicamada.
BR0009770A (pt) Derivados de bisindóis indigóides capazes de penetrarem na membrana de células, formulação farmacêutica e utilização da mesma
NO163776C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazoquinoksaliner.
DE68909772D1 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
WO2001087227A3 (en) Drug containing polymeric micelles
DE59804823D1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
PT1181047E (pt) Composicao compreendendo esfingomielinase alcalina para utilizacao como preparacao distetica suplemento alimentar ou produto farmaceutico
TR200100021T2 (tr) Kandaki yağ değerlerini etkileyen en az bir etki maddesine sahip bileşim
CA2322878A1 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
AU3401093A (en) Therapeutic agent for threatened abortion
DE60002043D1 (de) 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b]indol-1-carboxamid-derivate, ihre herstellung und therapeutische verwendung
WO2002017952A3 (en) Inhibition of mitogen-activated protein kinase (mapk) pathway: a selective therapeutic strategy against melanoma
DE59107240D1 (de) Emulgatorfreie Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe und ihre Herstellung
FR2572932B1 (fr) Medicament insoluble administre localement dans l'oreille
FR2786699B1 (fr) Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
AUPQ223999A0 (en) Intracellular feedback controls in the diagnosis and treatment of human disease
DE69926633D1 (de) Injizierbare arzneiformulierungen von partricin derivaten
GR900100420A (el) Μεθοδος για την παραγωγη πηγματος πολυακριλικου νατριου.
NO20022739L (no) Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)-2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on og nevroleptika for behandling eller forhindring av psykotiske lidelser
Clarke Light and health